Form 8-K - Current report:
SEC Accession No. 0001378325-26-000002
Filing Date
2026-03-13
Accepted
2026-03-13 16:32:38
Documents
13
Period of Report
2026-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cv-20260313.htm   iXBRL 8-K 30467
2 EX-10.1 cv-20260313xex101.htm EX-10.1 14729
  Complete submission text file 0001378325-26-000002.txt   173679

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cv-20260313.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cv-20260313_lab.xml EX-101.LAB 24599
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cv-20260313_pre.xml EX-101.PRE 14114
15 EXTRACTED XBRL INSTANCE DOCUMENT cv-20260313_htm.xml XML 2906
Mailing Address 18805 COX AVENUE SUITE 250 SARATOGA CA 95070
Business Address 18805 COX AVENUE SUITE 250 SARATOGA CA 95070 (408) 370-4790
CapsoVision, Inc (Filer) CIK: 0001378325 (see all company filings)

EIN.: 203369494 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42705 | Film No.: 26752968
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)